» Articles » PMID: 34385693

A Neurovascular-unit-on-a-chip for the Evaluation of the Restorative Potential of Stem Cell Therapies for Ischaemic Stroke

Overview
Journal Nat Biomed Eng
Publisher Springer Nature
Date 2021 Aug 13
PMID 34385693
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

The therapeutic efficacy of stem cells transplanted into an ischaemic brain depends primarily on the responses of the neurovascular unit. Here, we report the development and applicability of a functional neurovascular unit on a microfluidic chip as a microphysiological model of ischaemic stroke that recapitulates the function of the blood-brain barrier as well as interactions between therapeutic stem cells and host cells (human brain microvascular endothelial cells, pericytes, astrocytes, microglia and neurons). We used the model to track the infiltration of a number of candidate stem cells and to characterize the expression levels of genes associated with post-stroke pathologies. We observed that each type of stem cell showed unique neurorestorative effects, primarily by supporting endogenous recovery rather than through direct cell replacement, and that the recovery of synaptic activities is correlated with the recovery of the structural and functional integrity of the neurovascular unit rather than with the regeneration of neurons.

Citing Articles

Microfluidic tools to model, monitor, and modulate the gut-brain axis.

Kim H, Girardi G, Pickle A, Kim T, Seker E Biomicrofluidics. 2025; 19(2):021301.

PMID: 40060273 PMC: 11890156. DOI: 10.1063/5.0253041.


Vascularized tumor on a microfluidic chip to study mechanisms promoting tumor neovascularization and vascular targeted therapies.

Skubal M, Larney B, Phung N, Desmaras J, Dozic A, Volpe A Theranostics. 2025; 15(3):766-783.

PMID: 39776800 PMC: 11700857. DOI: 10.7150/thno.95334.


Glutamine metabolism is systemically different between primary and induced pluripotent stem cell-derived brain microvascular endothelial cells.

Weber C, Moiz B, Kheradmand M, Scott A, Kettula C, Wunderler B J Cereb Blood Flow Metab. 2025; 271678X241310729.

PMID: 39763385 PMC: 11705297. DOI: 10.1177/0271678X241310729.


Anatomically and Physiologically Accurate Engineered Neurovascular Unit and Blood-Brain Barrier Model Using Microvessels Isolated from Postmortem Human Brain Tissue.

OGrady B, McCall A, Cullison S, Chavarria D, Kjar A, Schrag M bioRxiv. 2024; .

PMID: 39386654 PMC: 11463414. DOI: 10.1101/2024.09.26.615283.


Drug Delivery Targeting Neuroinflammation to Treat Brain Diseases.

Wang J, Jia R, Wan W, Han H, Wang G, Li Z Bioconjug Chem. 2024; 35(11):1687-1698.

PMID: 39377704 PMC: 11583976. DOI: 10.1021/acs.bioconjchem.4c00414.


References
1.
Wang Y, Cai Y . Obtaining Human Ischemic Stroke Gene Expression Biomarkers from Animal Models: A Cross-species Validation Study. Sci Rep. 2016; 6:29693. PMC: 4942769. DOI: 10.1038/srep29693. View

2.
Stonesifer C, Corey S, Ghanekar S, Diamandis Z, Acosta S, Borlongan C . Stem cell therapy for abrogating stroke-induced neuroinflammation and relevant secondary cell death mechanisms. Prog Neurobiol. 2017; 158:94-131. PMC: 5671910. DOI: 10.1016/j.pneurobio.2017.07.004. View

3.
Wechsler L, Bates D, Stroemer P, Andrews-Zwilling Y, Aizman I . Cell Therapy for Chronic Stroke. Stroke. 2018; 49(5):1066-1074. DOI: 10.1161/STROKEAHA.117.018290. View

4.
McGonigle P, Ruggeri B . Animal models of human disease: challenges in enabling translation. Biochem Pharmacol. 2013; 87(1):162-71. DOI: 10.1016/j.bcp.2013.08.006. View

5.
Savitz S, Cramer S, Wechsler L . Stem cells as an emerging paradigm in stroke 3: enhancing the development of clinical trials. Stroke. 2013; 45(2):634-9. PMC: 5823253. DOI: 10.1161/STROKEAHA.113.003379. View